Ir. Doyle et al., SERUM SURFACTANT PROTEIN-A LEVELS IN PATIENTS WITH ACUTE CARDIOGENIC PULMONARY-EDEMA AND ADULT-RESPIRATORY-DISTRESS-SYNDROME, American journal of respiratory and critical care medicine, 152(1), 1995, pp. 307-317
Citations number
46
Categorie Soggetti
Emergency Medicine & Critical Care","Respiratory System
Detection of alveole-capillary damage has important implications for t
reatment modalities in ventilated patients. Although surfactant protei
n-A (SP-A) is normally only found in appreciable amounts in the lung,
we describe significantly elevated concentrations in the sera of patie
nts with acute cardiogenic pulmonary edema (median, 250 ng/ml; range,
180 to 364; n = 10) and in those with the adult respiratory distress s
yndrome (ARDS) (median, 378 ng/ml; range, 215 to 1,378; n = 15) relati
ve to healthy control subjects (median, 175 ng/ml; range, 123 to 248;
n = 15) and ventilated patients with no cardiorespiratory disease (med
ian, 169 ng/ml; range, 126 to 253; n = 6) (p < 0.01, in all cases). Se
rum SP-A was inversely related to blood oxygenation and to static resp
iratory system compliance both at the time of the patient's entry into
the study (p < 0.005, r(s) = -0.51, n = 31; p < 0.001, r(s) = 0.82, n
= 17; respectively) and during the course of admission (p < 0.001, r(
s) = -0.34, n = 168; p < 0.001, r(s) = -0.50, n = 111; respectively).
In addition, we describe in detail three cases of ARDS where lung func
tion either improved, remained static, or deteriorated. We conclude th
at serum SP-A is an acute indicator of lung function and alveolo-capil
lary membrane injury.